NuCana is on its way to open a Global Phase III study of Acelarin in combination with cisplatin for patients who are suffering from the disease in 2019 NuCana plc recently announced that it has received Orphan Drug Designation for Acelarin....

Users are able to spend cryptocurrencies such as Ethereum, Litecoin and Bitcoin in any store or online platform where merchants accept Visa Coinbase, a California based digital currency exchange, recently announced the launch of its crypto....

A US-based pharmaceutical company, Aerpio Pharmaceuticals, Inc., recently announced the initiation of Phase 1b clinical trial of AKB-9778 to develop treatment of PAOG (primary open angle glaucoma), report sources. For the record, Aerpio Ph....

Polivy is an innovative antibody-drug conjugate developed with an intention of targeting specific cells Reports confirm that the US Food and Drug Administration has awarded accelerated approval to Polivy (polatuzumab vedotin-piiq), for use....

The new data further supports the potential of Dance 501 inhaled insulin in Type 2 diabetes patients Dance Biopharm Holdings, Inc has recently presented Phase 2 Samba 04 clinical study results for its preservative free inhaled human insuli....

A clinical stage oncology drug development company Xynomic Pharmaceuticals Holdings, Inc. has reportedly announced that it has dosed the first patient in a Phase 1/2 trial. Apparently, the trial combines abexinostat with ibrutinib in patien....

· The company announced that the clinical trial failed to fulfil the first of the two preestablished endpoints. · Citing the result of the analysis, Takeda Pharma has decided to permanently halt the trial. Takeda Pharmaceuti....

Clinical stage biopharmaceutical company American BriVision has reportedly released positive outcomes of its ABV-1504 Phase II clinical trial, under Taiwan FDA clinical protocol code of BLI-1005-002 and the U.S. Food and Drug Administration....

MediLedger is preparing to launch its pilot alongside the U.S. FDA to try and reach the 2023 target to deliver a digitized system for tracking and verifying prescription drugs. Global retail giant, Walmart Inc. is reportedly expanding....

Clinical-stage biopharmaceutical company Mersana Therapeutics, Inc. has reportedly presented interim efficiency and safety data from its current Phase 1 dose-escalation study evaluating its first-in-class ADC candidate XMT-1536 aimed at NaP....